Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1F 18 T807----2件: 2, 127 💬
2F-18----2件: 5, 127 💬
3F-18 3F4AP----1件: 13 💬
4F-18 AV 1451----2件: 5, 127 💬
5F-18 FDG----1件: 127 💬
6F-18 FEDAA1106 (BAY85-8101)----1件: 13 💬
7F-18 FPCIT----1件: 6 💬
8F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid)----1件: 299 💬
9F13CD----1件: 288 💬
10F18CETO----1件: 75 💬
11F8IL10----2件: 46, 97 💬
12F8VR----1件: 288 💬
13FAB122----1件: 2 💬
14FABRAZYME1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
15Fabrazyme (agalsidase beta)1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
16Fabrazyme (agalsidase beta) 1 mg/kg1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
17FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
18Fabrazyme 35 mg1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
19Fabrazyme 5 mg1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
20FACS analyses----1件: 65 💬
21FACTANE 200 IU/ml----1件: 288 💬
22Factor VIII1件: Beroctocog alfa---1件: 288 💬
23Factor VIII concentrate1件: Beroctocog alfa---1件: 288 💬
24Factor von Willebrand1件: Von Willebrand factor human---1件: 288 💬
25FACTOR X1件: Coagulation factor X human---1件: 288 💬
26Factor XIIa antagonist monoclonal antibody----1件: 85 💬
27Factor XIII1件: Factor XIII (human)---3件: 51, 97, 288 💬
28Factor XIII Concentrate (Human)1件: Factor XIII (human)---1件: 288 💬
29Factor XIII Concentrate (Human), Pasteurized1件: Factor XIII (human)---1件: 288 💬
30Faecal matter----1件: 97 💬
31Faecal Microbiota Transplant----1件: 97 💬
32Faecal microbiota transplantation----5件: 46, 84, 96, 97, 271 💬
33Faecal sampling----1件: 46 💬
34FAM Therapy----1件: 228 💬
35FamC-1----1件: 2 💬
36Famciclovir1件: Famciclovir1件: Famciclovir 💬 --2件: 11, 13 💬
37FAMOTIDINA1件: Famotidine1件: Famotidine 💬 1件: HRH2 💬 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬1件: 61 💬
38Famotidine1件: Famotidine1件: Famotidine 💬 1件: HRH2 💬 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬5件: 6, 46, 86, 98, 107 💬
39Famotidine 20 MG1件: Famotidine1件: Famotidine 💬 1件: HRH2 💬 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬1件: 86 💬
40FAMPRIDINA1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
41FAMPRIDINE1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14 💬
42Fampridine SR1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
43Fampridine-SR1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
44Fampridine-SR b.i.d. (Twice Daily)1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
45FAMPYRA1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14 💬
46FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14)1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
47Fampyra 10 mg prolonged-release tablets2件: Dalfampridine,
Manganese citrate		1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
48Fampyra 10mg prolonged release tablets2件: Dalfampridine,
Manganese citrate		1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
49Fang yi qing feng shi granule----1件: 46 💬
50FANG(30)----1件: 46 💬
51Fanhdi----1件: 288 💬
52FANHDI 100 UI----1件: 288 💬
53Fanhdi 100 UI FVIII-120 UI FVW----1件: 288 💬
54FANHDI 25 UI----1件: 288 💬
55Fanhdi 25 UI FVIII-30 UI FVW----1件: 288 💬
56FANHDI 250UI*1F 250UI+F 10ML----1件: 288 💬
57FANHDI 50 UI----1件: 288 💬
58Fanhdi 50 UI FVIII-60 UI FVW----1件: 288 💬
59FANHDI*INF FL 250UI+SIR SOLV+S----1件: 288 💬
60FANHDI*INF FL 500UI+SIR SOLV+S----1件: 288 💬
61FANHDI*INF FL1000UI+SIR SOLV+S----1件: 288 💬
62FANHDI*INF FL250UI+SIR SOLV+S----1件: 288 💬
63Fansidar (pyrimethamine and sulfadoxine)2件: Pyrimethamine,
Sulfadoxine		2件: Pyrimethamine ,
Sulfadoxine 💬 		--1件: 65 💬
64Fasenra1件: Benralizumab1件: Benralizumab 💬 1件: IL5RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299 💬
65Faslodex1件: Fulvestrant1件: Fulvestrant 💬 2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 49 💬
66Fasudil1件: Fasudil1件: Fasudil 💬 2件: ROCK1,
ROCK2 💬 		23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 2, 5, 7, 51 💬
67Fasudil (WP-0512)1件: Fasudil1件: Fasudil 💬 2件: ROCK1,
ROCK2 💬 		23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
68FASUDIL HYDROCHLORIDE1件: Fasudil1件: Fasudil 💬 2件: ROCK1,
ROCK2 💬 		23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
69Fat diet----1件: 78 💬
70Fatigue----1件: 13 💬
71FAXE Kondi----1件: 257 💬
72Faxe Kondi Free----1件: 257 💬
73Fazisiran Injection----1件: 231 💬
74FB-101----1件: 6 💬
75FB704A----1件: 46 💬
76FBL-MTX----1件: 46 💬
77FBS0701----1件: 284 💬
78FBS0701 CAPSULE----1件: 284 💬
79FBS0701/SSP004184----1件: 284 💬
80FBX-101----1件: 19 💬
81Fc- and CDR-modified humanised monoclonal antibody against C5----3件: 11, 62, 109 💬
82FCM----1件: 222 💬
83FCR001----1件: 51 💬
84FCX-007----1件: 36 💬
85FCX-013----1件: 51 💬
86FDC macitentan/tadalafil2件: Macitentan,
Tadalafil		2件: Tadalafil ,
Macitentan 💬 		3件: EDNRA,
EDNRB,
PDE5A 💬 		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
87FDG----1件: 84 💬
88FDL1691件: FDL169---1件: 299 💬
89FDL176----1件: 299 💬
90FDL176 & FDL169 coadministration1件: FDL169---1件: 299 💬
91FE 992097----1件: 193 💬
92FE 999301----2件: 96, 97 💬
93Feburane----1件: 21 💬
94Febuxostat1件: Febuxostat1件: Febuxostat 💬 1件: XDH 💬 6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬3件: 2, 6, 13 💬
95Fecal Microbial transplant----2件: 96, 97 💬
96Fecal microbial transplant (FMT)----1件: 13 💬
97Fecal Microbial Transplantation----2件: 96, 97 💬
98Fecal Microbial Transplants----1件: 13 💬
99Fecal microbiota----3件: 13, 96, 97 💬
100Fecal microbiota capsule----1件: 97 💬
101Fecal Microbiota Enema----1件: 97 💬
102Fecal Microbiota Transplant----2件: 96, 97 💬
103Fecal Microbiota Transplant (FMT)----2件: 96, 97 💬
104Fecal microbiota transplantation----5件: 2, 66, 94, 96, 97 💬
105Fecal Microbiota Transplantation (FMT)----2件: 96, 97 💬
106Fecal Microbiota Transplantation (FMT), OpenBiome----1件: 97 💬
107Fecal Microbiota Transplantation by Intra-rectal enemas----1件: 97 💬
108Fecal Microbiota Transplantation by Stool capsules----1件: 97 💬
109Fecal transplantation----1件: 97 💬
110Felzartamab1件: Felzartamab---2件: 66, 222 💬
111Femoston 1/10----1件: 13 💬
112Femoston 2/10----1件: 13 💬
113Fendrix1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
114Fendrix suspension for injection1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
115Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed).1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
116FENEBRUTINIB1件: Fenebrutinib1件: Fenebrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 13 💬
117Fenfluramina1件: Fenfluramine1件: Fenfluramine 💬 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬 		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬2件: 140, 144 💬
118Fenfluramina Cloridrato1件: Fenfluramine1件: Fenfluramine 💬 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬 		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬2件: 140, 144 💬
119FENFLURAMINE1件: Fenfluramine1件: Fenfluramine 💬 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬 		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬4件: 140, 144, 145, 149 💬
120Fenfluramine HCl, DL-Fenfluramine, (±)-Fenfluramine1件: Fenfluramine1件: Fenfluramine 💬 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬 		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬1件: 144 💬
121FENFLURAMINE HYDROCHLORIDE1件: Fenfluramine1件: Fenfluramine 💬 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬 		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬2件: 140, 144 💬
122FENFLURAMINE HYDROCHLORIDE (colorless)1件: Fenfluramine1件: Fenfluramine 💬 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬 		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬2件: 140, 144 💬
123FENFLURAMINE HYDROCHLORIDE (red)1件: Fenfluramine1件: Fenfluramine 💬 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬 		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬1件: 140 💬
124Fengshigutong Capsule----1件: 271 💬
125Fengshigutong Capsule plus Imrecoxib1件: Imrecoxib---1件: 271 💬
126Fenilbutirato----1件: 2 💬
127Fenofibrate1件: Fenofibrate1件: Fenofibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬6件: 8, 79, 93, 94, 97, 265 💬
128Fenofibrate 160mg1件: Fenofibrate1件: Fenofibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 97 💬
129Fenofibrate 200mg1件: Fenofibrate1件: Fenofibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
130Fenofibrate Combined With Ursodeoxycholic Acid2件: Fenofibrate,
Ursodeoxycholic acid		2件: Fenofibrate ,
Ursodiol 💬 		2件: NR1H4,
PPARA 💬 		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
131Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)1件: Fenofibrate1件: Fenofibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
132Fenretinide1件: Fenretinide1件: Fenretinide 💬 2件: RARA,
RARB 💬 		8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 299 💬
133Fentanyl1件: Fentanyl1件: Fentanyl 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬3件: 46, 70, 215 💬
134Fentanyl (High Dose)1件: Fentanyl1件: Fentanyl 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 215 💬
135Fentanyl (Low Dose)1件: Fentanyl1件: Fentanyl 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 215 💬
136Fentanyl (Low Dose) + Dexmedetomidine2件: Dexmedetomidine,
Fentanyl		2件: Fentanyl ,
Dexmedetomidine 💬 		4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬 		4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
137Fentanyl transdermal patch1件: Fentanyl1件: Fentanyl 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 46 💬
138Feraheme1件: Ferumoxytol1件: Ferumoxytol 💬 --1件: 13 💬
139Ferinject----2件: 86, 299 💬
140Ferinject or CosmoFer----1件: 86 💬
141Fermented oyster extract1件: Oyster---1件: 84 💬
142Ferric Carboxy Maltose1件: Maltose1件: Maltose 💬 --1件: 96 💬
143FERRIC CARBOXYMALTOSE1件: Ferric carboxymaltose1件: Ferric carboxymaltose 💬 --4件: 86, 96, 97, 299 💬
144Ferric Maltol1件: Ferric maltol1件: Ferric maltol 💬 --1件: 96 💬
145Ferricarboxymaltose----1件: 86 💬
146Ferriprox1件: Deferiprone1件: Deferiprone 💬 --2件: 6, 120 💬
147Ferriprox 500 mg1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
148FERRIPROX*100CPR RIV 500MG1件: Deferiprone1件: Deferiprone 💬 --1件: 120 💬
149Ferrograd----1件: 46 💬
150Ferrograd Folic Tablets----1件: 46 💬
151Ferrous sulfate 325mg1件: Sulfate ion---1件: 299 💬
152Ferrous sulphate----2件: 96, 97 💬
153Ferrous sulphate 200mg oral tablet----1件: 227 💬
154Ferrprox (Deferiprone)1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
155Ferulic acid1件: Ferulic acid---1件: 127 💬
156Ferumoxytol1件: Ferumoxytol1件: Ferumoxytol 💬 --1件: 13 💬
157Fesoterodine1件: Fesoterodine1件: Fesoterodine 💬 2件: CHRM2,
CHRM3 💬 		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
158Fetal porcine cells, Neurocell-PD----1件: 6 💬
159Fexinidazole1件: Fexinidazole1件: Fexinidazole 💬 --1件: 65 💬
160Fexofenadine1件: Fexofenadine1件: Fexofenadine 💬 1件: HRH1 💬 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬2件: 13, 46 💬
161FFP104----2件: 93, 96 💬
162FG-3019----3件: 85, 113, 222 💬
163FG-3019 10mg/mL in 10 mL vials----1件: 85 💬
164Fibrate treatment----1件: 160 💬
165Fibrin1件: Fibrin---1件: 279 💬
166Fibrinogen1件: Fibrinogen human---2件: 14, 65 💬
167Fibrinogen (coagulation factorI)1件: Fibrinogen human---1件: 65 💬
168Fibrinogen concentrate1件: Fibrinogen human---1件: 14 💬
169Fibrinogen Concentrate from Human Plasma1件: Fibrinogen human---1件: 65 💬
170Fibroblasts----1件: 36 💬
171Fibrogammin P----1件: 288 💬
172Fibrogammin® 1250----1件: 51 💬
173Fibrogammin® P----1件: 288 💬
174Fibrogammin®P----1件: 288 💬
175Fibrogammin®P, coagulation factor XIII concentrate (Human)1件: Factor XIII (human)---1件: 51 💬
176Fibrovein----1件: 279 💬
177Fibrovein 3%----1件: 279 💬
178Fig1件: Fig---1件: 2 💬
179Filamentous haemagglutinin1件: Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)---1件: 46 💬
180Filamentous haemagglutinin adsorbed1件: Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)---1件: 46 💬
181FILGOTINIB1件: Filgotinib1件: Filgotinib 💬 1件: JAK1 💬 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬6件: 46, 53, 96, 97, 222, 271 💬
182Filgotinib 200mg/day1件: Filgotinib1件: Filgotinib 💬 1件: JAK1 💬 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
183Filgrastim1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬28件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
184Filgrastim (G-CSF)1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 331 💬
185Filgrastim Hexal1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
186Filgrastim, Alemtuzumab2件: Alemtuzumab,
Filgrastim		2件: Alemtuzumab ,
Filgrastim 💬 		2件: CD52,
CSF3R 💬 		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
187Film-coated tablet----1件: 97 💬
188Finamine tablets----1件: 6 💬
189Finasteride1件: Finasteride1件: Finasteride 💬 1件: SRD5A2 💬 3件: Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬1件: 6 💬
190Finely ground flaxseed powder1件: Flax seed---1件: 299 💬
191Fingolimob----1件: 13 💬
192Fingolimob (FTY)----1件: 13 💬
193FINGOLIMOD1件: Fingolimod1件: Fingolimod 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156 💬
194Fingolimod (FTY720)1件: Fingolimod1件: Fingolimod 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 156 💬
195Fingolimod 0.5 mg1件: Fingolimod1件: Fingolimod 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
196Fingolimod 0.5mg1件: Fingolimod1件: Fingolimod 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
197Fingolimod 1.25 mg1件: Fingolimod1件: Fingolimod 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
198FINGOLIMOD HYDROCHLORIDE1件: Fingolimod1件: Fingolimod 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
199Fingolimodi----1件: 13 💬
200Fingolmod----1件: 13 💬
201Fipamezole1件: Fipamezole---2件: 6, 17 💬
202Fipamezole hydrochloride1件: Fipamezole---2件: 6, 17 💬
203Fipamezole hydrochloride 30 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
204Fipamezole hydrochloride 60 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
205Fipamezole hydrochloride 90 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
206Fipamezole ODT1件: Fipamezole---1件: 6 💬
207Fipamezole ODT Cohort 21件: Fipamezole---1件: 6 💬
208Firategrast1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
209Firategrast (USAN approved name)1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
210Firategrast 150 mg1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
211Firategrast 300 mg1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
212Firategrast gastro-retentive solution1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
213Firategrast immediate release tablet1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
214Firategrast modified release tablet1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
215Firdapse1件: Amifampridine1件: Amifampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 11 💬
216FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE1件: Amifampridine1件: Amifampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 11 💬
217First line DMT----1件: 13 💬
218Fisetin1件: Fisetin---1件: 65 💬
219Fish Oil1件: Fish oil---8件: 13, 46, 49, 66, 96, 260, 294, 299 💬
220Fish oil concentrate1件: Fish oil---1件: 13 💬
221Fish oil supplement1件: Fish oil---1件: 46 💬
222Fish oil, gamma-linolenic acid3件: Fish oil,
Gamolenic acid,
alpha-Linolenic acid		1件: Gamolenic acid 💬 --1件: 46 💬
223FISH OIL, RICH IN OMEGA-3-ACIDS2件: Fish oil,
Omega-3 fatty acids		---1件: 13 💬
224FISH OIL,RICH IN OMEGA 3 ACIDS1件: Fish oil---1件: 13 💬
225FITC-Adalimumab1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
226Fixed dose combination Ciprofloxacin/Celecoxib2件: Celecoxib,
Ciprofloxacin		2件: Ciprofloxacin ,
Celecoxib 💬 		1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 2 💬
227FK-506----1件: 60 💬
228FK506----1件: 222 💬
229FK506 level 2-3 ng/ml----1件: 86 💬
230FK506 level 3-5 ng/ml----1件: 86 💬
231FK506 level < 2 ng/ml----1件: 86 💬
232FKB327----1件: 46 💬
233FKB327 AI----1件: 46 💬
234FKB327 PFS----1件: 46 💬
235Flagyl1件: Metronidazole1件: Metronidazole 💬 --2件: 96, 97 💬
236Flavocoxid----1件: 113 💬
237Flavoxate1件: Flavoxate1件: Flavoxate 💬 16件: PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬 		18件: Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
238Flaxseed1件: Flax seed---2件: 97, 299 💬
239Flaxseed lignan-enriched complex (FLC)1件: Flax seed---1件: 97 💬
240FLEBOGAMMA 5%----1件: 15 💬
241Flebogamma 5% DIF----1件: 65 💬
242Flecainide1件: Flecainide1件: Flecainide 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
243FLECAINIDE ACETATE2件: Acetate,
Flecainide		1件: Flecainide 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
244Flecainidum1件: Flecainide1件: Flecainide 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
245Flixabi1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
246Flolan1件: Epoprostenol1件: Epoprostenol 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
247FLOLAN injection with currently marketed diluent1件: Epoprostenol1件: Epoprostenol 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
248FLOLAN injection with reformulated diluent1件: Epoprostenol1件: Epoprostenol 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
249FLOLAN TM and Glycine Diluent2件: Epoprostenol,
Glycine		2件: Glycine ,
Epoprostenol 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
250Flolan®1件: Epoprostenol1件: Epoprostenol 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
251FLOLAN™ and Glycine Diluent2件: Epoprostenol,
Glycine		2件: Glycine ,
Epoprostenol 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
252FLORBETABEN (18F)----1件: 6 💬
253Florbetapir (18F)----1件: 127 💬
254Florbetapir 18F----1件: 127 💬
255Florbetapir 18F Injection----1件: 127 💬
256Florbetapir F 18----1件: 6 💬
257Florence 30 µg/mL----1件: 98 💬
258Florence 60 µg/mL----1件: 98 💬
259Florence 90 µg/mL----1件: 98 💬
260Flortaucipir1件: Flortaucipir1件: Flortaucipir F 18 💬 1件: MAPT 💬 4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬3件: 5, 7, 127 💬
261Flortaucipir F181件: Flortaucipir1件: Flortaucipir F 18 💬 1件: MAPT 💬 4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬3件: 5, 7, 127 💬
262Floseal----1件: 227 💬
263Flovent----1件: 98 💬
264FLT190----1件: 19 💬
265FLT201----1件: 19 💬
266Flu-ATG----1件: 60 💬
267Flucinolone acetonide----1件: 56 💬
268FLUCLOXACILLIN1件: Flucloxacillin1件: Floxacillin 💬 --1件: 299 💬
269Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution1件: Flucloxacillin1件: Floxacillin 💬 --1件: 299 💬
270FLUCLOXACILLIN SODIUM1件: Flucloxacillin1件: Floxacillin 💬 --1件: 299 💬
271Flucloxicillin----1件: 299 💬
272FLUCONAZOLE1件: Fluconazole1件: Fluconazole 💬 --2件: 96, 225 💬
273FLUDARA1件: Fludarabine1件: Fludarabine 💬 1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
274Fludarabina1件: Fludarabine1件: Fludarabine 💬 1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 19, 65 💬
275Fludarabina Accord1件: Fludarabine1件: Fludarabine 💬 1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
276FLUDARABINA ACCORD - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 5 FLACONCINI IN VETRO DA 2 ML1件: Fludarabine1件: Fludarabine 💬 1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 19 💬
277FLUDARABINA FOSFATO1件: Fludarabine1件: Fludarabine 💬 1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 19 💬
278FLUDARABINA TEVA - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO DI VETRO DA 2 ML1件: Fludarabine1件: Fludarabine 💬 1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
279Fludarabine1件: Fludarabine1件: Fludarabine 💬 1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬19件: 11, 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 💬
280Fludarabine (FLU)1件: Fludarabine1件: Fludarabine 💬 1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 60, 285 💬
281Fludarabine monophosphate1件: Fludarabine1件: Fludarabine 💬 1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬3件: 65, 284, 326 💬
282Fludarabine phosphate2件: Fludarabine,
Phosphate ion		1件: Fludarabine 💬 1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬12件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 💬
283Fludarabine phosphate 30 mg2件: Fludarabine,
Phosphate ion		1件: Fludarabine 💬 1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164 💬
284Fludarabine phosphate 40 mg2件: Fludarabine,
Phosphate ion		1件: Fludarabine 💬 1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164 💬
285Fludarabine, Busulfan, Thymoglobulin3件: Antithymocyte immunoglobulin (rabbit),
Busulfan,
Fludarabine		2件: Busulfan ,
Fludarabine 💬 		1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
286Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
287Fludarabine, Melphalan, Thiotepa3件: Fludarabine,
Melphalan,
Thiotepa		3件: Melphalan ,
Thiotepa ,
Fludarabine 💬 		1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
288Fludarabine/ melphalan2件: Fludarabine,
Melphalan		2件: Melphalan ,
Fludarabine 💬 		1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
289Fludarabine/busulfan2件: Busulfan,
Fludarabine		2件: Busulfan ,
Fludarabine 💬 		1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
290Fludeoxyglucose1件: Fludeoxyglucose1件: Fludeoxyglucose F 18 💬 --3件: 84, 85, 88 💬
291Fludrocortisone1件: Fludrocortisone1件: Fludrocortisone 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬3件: 6, 17, 81 💬
292Fluimucil----4件: 85, 94, 193, 298 💬
293Fluimucil (acetylcysteine)1件: Acetylcysteine1件: Acetylcysteine 💬 --1件: 193 💬
294FLUIMUCIL*20CPR EFF 600MG----2件: 94, 298 💬
295Fluimucil® 600 mg effervescent tablets----1件: 85 💬
296Flumazenil1件: Flumazenil1件: Flumazenil 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬5件: 6, 13, 17, 18, 206 💬
297FluMist10件: Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen,
Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen,
Influenza A virus A/South Dakota/6/2007 (H1N1) live (attenuated) antigen,
Influenza A virus A/Uruguay/716/2007(H3N2) live (attenuated) antigen,
Influenza A virus A/Victoria/361/2011 (H3N2) live (attenuated) antigen,
Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen,
Influenza B virus B/Wisconsin/1/2010 live (attenuated) antigen,
Influenza virus type A (H1N1),
Influenza virus type A (H3N2),
Influenza virus type B		---1件: 299 💬
298Flumist®10件: Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen,
Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen,
Influenza A virus A/South Dakota/6/2007 (H1N1) live (attenuated) antigen,
Influenza A virus A/Uruguay/716/2007(H3N2) live (attenuated) antigen,
Influenza A virus A/Victoria/361/2011 (H3N2) live (attenuated) antigen,
Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen,
Influenza B virus B/Wisconsin/1/2010 live (attenuated) antigen,
Influenza virus type A (H1N1),
Influenza virus type A (H3N2),
Influenza virus type B		---1件: 299 💬
299Fluocinolone1件: Fluocinolone---1件: 90 💬
300Fluocinolone Acetonide2件: Fluocinolone,
Fluocinolone acetonide		1件: Fluocinolone acetonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 90 💬
301Fluorescein1件: Fluorescein1件: Fluorescein 💬 --2件: 22, 97 💬
302Fluorescence in situ hybridization----1件: 285 💬
303Fluorescite----1件: 215 💬
304FLUORINE (18F) FLUDEOXYGLUCOSE1件: Fludeoxyglucose1件: Fludeoxyglucose F 18 💬 --2件: 84, 85 💬
305FLUORINE-181件: Fluorine F-181件: Sodium fluoride F 18 💬 --1件: 41 💬
306Fluorodeoxyglucose----1件: 84 💬
307Fluoxetin1件: Fluoxetine1件: Fluoxetine 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬3件: 13, 179, 206 💬
308Fluoxetin Hexal1件: Fluoxetine1件: Fluoxetine 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13 💬
309FLUOXETINE1件: Fluoxetine1件: Fluoxetine 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 13, 17, 78, 86 💬
310FLUOXETINE HYDROCHLORIDE1件: Fluoxetine1件: Fluoxetine 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13 💬
311Fluoxétine1件: Fluoxetine1件: Fluoxetine 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 17 💬
312Flupentixol1件: Flupentixol1件: Flupentixol 💬 2件: DRD1,
DRD2 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 97 💬
313Flupirtin----1件: 13 💬
314Flupirtine1件: Flupirtine1件: Flupirtine 💬 --1件: 13 💬
315Flupirtinmaleat----1件: 13 💬
316FLURBIPROFEN1件: Flurbiprofen1件: Flurbiprofen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬3件: 13, 21, 46 💬
317Flutamide1件: Flutamide1件: Flutamide 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 81 💬
318Flutemetamol1件: Flutemetamol---4件: 5, 6, 7, 127 💬
319Fluticasone2件: Fluticasone,
Fluticasone propionate		2件: Fluticasone propionate ,
Fluticasone 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 98, 228, 299 💬
320Fluticasone MDI1件: Fluticasone1件: Fluticasone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
321FLUTICASONE PROPIONATE2件: Fluticasone,
Fluticasone propionate		2件: Fluticasone propionate ,
Fluticasone 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 98, 228 💬
322Fluticasone Propionate, USP2件: Fluticasone,
Fluticasone propionate		2件: Fluticasone propionate ,
Fluticasone 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
323Fluvastatin1件: Fluvastatin1件: Fluvastatin 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 79, 218, 222 💬
324Fluzone13件: Haemagglutinin-strain B,
Influenza A virus A/Brisbane/59/2007 (H1N1) antigen (formaldehyde inactivated),
Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated),
Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) antigen (formaldehyde inactivated),
Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (formaldehyde inactivated),
Influenza A virus A/Uruguay/716/2007(H3N2) antigen (formaldehyde inactivated),
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated),
Influenza A virus A/Victoria/361/2011 IVR-165 (H3N2) antigen (formaldehyde inactivated),
Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated),
Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (formaldehyde inactivated),
Influenza B virus B/Massachusetts/2/2012 antigen (formaldehyde inactivated),
Influenza B virus B/Phuket/3073/2013 antigen (formaldehyde inactivated),
Influenza B virus B/Texas/6/2011 antigen (formaldehyde inactivated)		---2件: 21, 49 💬
325Fluzone®13件: Haemagglutinin-strain B,
Influenza A virus A/Brisbane/59/2007 (H1N1) antigen (formaldehyde inactivated),
Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated),
Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) antigen (formaldehyde inactivated),
Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (formaldehyde inactivated),
Influenza A virus A/Uruguay/716/2007(H3N2) antigen (formaldehyde inactivated),
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated),
Influenza A virus A/Victoria/361/2011 IVR-165 (H3N2) antigen (formaldehyde inactivated),
Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated),
Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (formaldehyde inactivated),
Influenza B virus B/Massachusetts/2/2012 antigen (formaldehyde inactivated),
Influenza B virus B/Phuket/3073/2013 antigen (formaldehyde inactivated),
Influenza B virus B/Texas/6/2011 antigen (formaldehyde inactivated)		---1件: 21 💬
326FLX-787-ODT----1件: 2 💬
327FLX-787-ODT (orally disintegrating tablet)----1件: 10 💬
328FLX-787-ODT (orally disintigrating tablet)----1件: 2 💬
329FMP-30----1件: 53 💬
330FMP30 Donor Stool----1件: 13 💬
331FMT----2件: 96, 97 💬
332FMT enema----1件: 97 💬
333FMT infusions----1件: 97 💬
334FMT oral----1件: 97 💬
335Focetria----1件: 46 💬
336Focetria (Monovalent MF59-Adjuvanted vaccine)----3件: 46, 49, 271 💬
337Folate1件: Folic acid1件: Folic acid 💬 --3件: 41, 46, 49 💬
338FolateScan (Technetium Tc 99mEC20)----4件: 13, 46, 49, 96 💬
339Folic (or folinic) acid----1件: 46 💬
340Folic acid1件: Folic acid1件: Folic acid 💬 --5件: 6, 46, 49, 84, 296 💬
341Folic acid (non-investigational product)1件: Folic acid1件: Folic acid 💬 --1件: 46 💬
342Folic acid or folate1件: Folic acid1件: Folic acid 💬 --1件: 46 💬
343Folic Acid, Vitamin B6, Vitamin B123件: Cyanocobalamin,
Folic acid,
Pyridoxine		6件: Folic acid ,
Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 ,
Pyridoxine 💬 		--1件: 6 💬
344Folic/folinic acid1件: Leucovorin2件: Folinic acid ,
Folinic acid calcium salt pentahydrate 💬 		--2件: 46, 107 💬
345Foliglurax1件: Foliglurax---1件: 6 💬
346Foliglurax 10 mg (treatment A)1件: Foliglurax---1件: 6 💬
347Foliglurax 30 mg (treatment B)1件: Foliglurax---1件: 6 💬
348Folimet----1件: 46 💬
349Folinic acid1件: Leucovorin2件: Folinic acid ,
Folinic acid calcium salt pentahydrate 💬 		--3件: 46, 107, 320 💬
350Follow-up study of the treated cohort----1件: 193 💬
351Fontolizumab1件: Fontolizumab1件: Fontolizumab 💬 1件: IFNG 💬 32件: African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 46 💬
352Foralumab1件: Foralumab---2件: 13, 96 💬
353Fordadistrogene movaparvovec1件: Fordadistrogene movaparvovec---1件: 113 💬
354Forigerimod1件: Forigerimod1件: Forigerimod 💬 --1件: 49 💬
355FORLAX 4 g, poudre pour solution buvable en sachet----1件: 299 💬
356Formistin----1件: 13 💬
357FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE----1件: 13 💬
358Formistin 10 mg----1件: 13 💬
359Formoterol1件: Formoterol1件: Formoterol 💬 1件: ADRB2 💬 9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 85, 228, 299 💬
360Formoterol fumarate dihydrate1件: Formoterol1件: Formoterol 💬 1件: ADRB2 💬 9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
361Formoterol/Budesonide2件: Budesonide,
Formoterol		2件: Budesonide ,
Formoterol 💬 		2件: ADRB2,
NR3C1 💬 		9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
362Formulation A----1件: 13 💬
363Formulation B----1件: 13 💬
364Formulation C----1件: 13 💬
365Formulation D----1件: 13 💬
366Forsteo1件: Teriparatide1件: Teriparatide 💬 1件: PTH1R 💬 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬3件: 70, 235, 274 💬
367FORSTEO-R1件: Teriparatide1件: Teriparatide 💬 1件: PTH1R 💬 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
368FORTECORTIN----2件: 28, 65 💬
369Fortecortin Inject 40 mg Amp.----1件: 65 💬
370Forteo1件: Teriparatide1件: Teriparatide 💬 1件: PTH1R 💬 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 70 💬
371Fortiral----1件: 6 💬
372Fortum----1件: 299 💬
373Forxiga1件: Dapagliflozin1件: Dapagliflozin 💬 1件: SLC5A2 💬 -2件: 86, 88 💬
374Forxiga (dapagliflozin)1件: Dapagliflozin1件: Dapagliflozin 💬 1件: SLC5A2 💬 -2件: 86, 88 💬
375FOS----2件: 66, 96 💬
376Foscarbidopa1件: Foscarbidopa1件: Foscarbidopa 💬 --1件: 6 💬
377Foscarbidopa and Foslevodopa2件: Foscarbidopa,
Foslevodopa		2件: Foslevodopa ,
Foscarbidopa 💬 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
378Foscarnet1件: Foscarnet---1件: 60 💬
379FosD----1件: 46 💬
380Fosfamatinib Disodium----1件: 46 💬
381Fosfato sodico de dexametasona1件: Dexamethasone1件: Dexamethasone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
382Fosfomycin1件: Fosfomycin1件: Fosfomycin 💬 --2件: 96, 97 💬
383FOSFOMYCIN DISODIUM1件: Fosfomycin1件: Fosfomycin 💬 --1件: 97 💬
384Foslevodopa1件: Foslevodopa1件: Foslevodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
385Fosmetpantotenate----1件: 120 💬
386Fosmetpantotenate (RE-024)----1件: 120 💬
387FOSMETPANTOTENATE DRUG SUBSTANCE----1件: 120 💬
388Fosmetpantotenato----1件: 120 💬
389Fospropofol1件: Fospropofol---1件: 226 💬
390Fospropofol (Lusedra®) 101件: Fospropofol---1件: 226 💬
391Fospropofol (Lusedra®) 121件: Fospropofol---1件: 226 💬
392Fospropofol (Lusedra®) 6.51件: Fospropofol---1件: 226 💬
393Fostair----1件: 85 💬
394Fostamatinib1件: Fostamatinib1件: Fostamatinib 💬 1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬4件: 46, 49, 61, 66 💬
395Fostamatinib 100 mg1件: Fostamatinib1件: Fostamatinib 💬 1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
396Fostamatinib 100 mg tablet1件: Fostamatinib1件: Fostamatinib 💬 1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
397Fostamatinib 150 mg1件: Fostamatinib1件: Fostamatinib 💬 1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
398Fostamatinib 150 mg bid1件: Fostamatinib1件: Fostamatinib 💬 1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 61 💬
399Fostamatinib 150 mg tablet1件: Fostamatinib1件: Fostamatinib 💬 1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
400Fostamatinib 50 mg blue film-coated tablet1件: Fostamatinib1件: Fostamatinib 💬 1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
401Fostamatinib Disodium1件: Fostamatinib1件: Fostamatinib 💬 1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬3件: 46, 61, 66 💬
402Fostamatinib Disodium (R935788)1件: Fostamatinib1件: Fostamatinib 💬 1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬2件: 46, 49 💬
403Fostamatinib Disodium tablet 100 mg1件: Fostamatinib1件: Fostamatinib 💬 1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
404Fostamatinib Disodium tablet 150 mg1件: Fostamatinib1件: Fostamatinib 💬 1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
405FP-110----1件: 97 💬
406FP-CYA-050----1件: 97 💬
407FP-CYA-053----1件: 97 💬
408FPA008----1件: 46 💬
409FPF 300 (thalidomide)1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
410FPF1011----1件: 263 💬
411FPF1100NW----1件: 6 💬
412FPFS-1169----1件: 6 💬
413FPI-2620----1件: 127 💬
414FR104----1件: 46 💬
415Fragmin1件: Dalteparin---1件: 222 💬
416Frameshift Array blood sample test----1件: 34 💬
417Free amino acids intake1件: Amino acids---1件: 240 💬
418Freeze-dried black raspberry powder1件: Raspberry1件: Raspberry 💬 --1件: 97 💬
419Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS)1件: Human immunoglobulin G---3件: 14, 43, 45 💬
420Fremanezumab1件: Fremanezumab1件: Fremanezumab 💬 1件: CALCA 💬 2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬2件: 124, 226 💬
421Fresenius-Kabi)----1件: 46 💬
422Fresh Frozen Plasma----1件: 5 💬
423Fresolimumab1件: Fresolimumab1件: Fresolimumab 💬 3件: TGFB1,
TGFB2,
TGFB3 💬 		35件: AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬2件: 51, 222 💬
424Frisium----1件: 140 💬
425FRISIUM*30CPS 10MG----1件: 140 💬
426FRM-0334----1件: 127 💬
427From August 2020 'no additional treatment'----1件: 51 💬
428Frondanol----1件: 97 💬
429Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the a-L-iduronidase cDNA, in their final formulation medium.----1件: 19 💬
430FSME-IMMUN----1件: 46 💬
431FT011----1件: 51 💬
432FT011 100 mg----1件: 51 💬
433FT011 200 mg----1件: 51 💬
434FTI, AZLI----1件: 299 💬
435FTX-1821----1件: 113 💬
436FTY720----2件: 13, 14 💬
437FTY720D----1件: 13 💬
438FTY720I----1件: 14 💬
439Fucidin1件: Fusidic acid1件: Fusidic acid 💬 --1件: 299 💬
440Fucidin Tablets1件: Fusidic acid1件: Fusidic acid 💬 --1件: 299 💬
441Fucose1件: Fucose---1件: 65 💬
442Fully human anti-interferon gamma monoclonal antibody1件: Interferon Gamma---1件: 107 💬
443Fully human IgG1 monoclonal antibody specific for TL1A----2件: 96, 97 💬
444Fully human IgG2 lambda monoclonal antibody----1件: 172 💬
445Fully human monoclonal antibody directed against CXCL10----1件: 93 💬
446Fully humanised, recombinant monoclonal antibody (IgG1)----1件: 96 💬
447Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody----1件: 13 💬
448Fultium-D3 800IU capsules----1件: 274 💬
449Fulvestrant1件: Fulvestrant1件: Fulvestrant 💬 2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 86 💬
450Fumaderm----1件: 49 💬
451Fumaderm®----1件: 49 💬
452Fumaderm® initial----1件: 49 💬
453Fumaric acid1件: Fumaric acid1件: Fumaric acid 💬 --1件: 13 💬
454FURESTEM-RA Inj----1件: 46 💬
455FURESTEM-RA Inj.----1件: 46 💬
456Furosemide1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬2件: 6, 86 💬
457Furosemide Injection1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 6 💬
458Fusidate1件: Fusidic acid1件: Fusidic acid 💬 --1件: 299 💬
459FUSIDIC ACID1件: Fusidic acid1件: Fusidic acid 💬 --1件: 299 💬
460Fusidin----1件: 299 💬
461Fusion2件: Iron polymaltose,
Lactobacillus casei		1件: Lactobacillus casei 💬 --7件: 11, 13, 46, 49, 69, 70, 271 💬
462Fuzhenghuayu----1件: 93 💬
463Fx-1006A1件: Fx-1006A---1件: 28 💬
464FX125L----1件: 46 💬
465FXIIa inhibitor monoclonal antibody----1件: 85 💬
466FXIII Concentrate (Human)----1件: 288 💬
467FXIII Concentrate (Human) (FXIII)----1件: 288 💬
468Fycompa1件: Perampanel1件: Perampanel 💬 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬 		16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬2件: 2, 144 💬